Cited by 2

Leveraging Centralized Health System Data Management and Large Language Model–Based Data Preprocessing to Identify Predictors for Radiation Therapy Interruption

Kumsa, Fekede Asefa, Brett, Christopher L., Hashtarkhani, Soheil, Rashid, Rezaur, Chinthala, Lokesh, Zink, Janet A., Davis, Robert L., Shaban-Nejad, Arash +1 more·2025·JCO Clinical Cancer Informatics

Abstract

PURPOSE: Unplanned treatment interruptions represent an important care quality shortfall for patients undergoing cancer radiotherapy. This study aimed to evaluate use of a centralized electronic health record warehouse and large language model–based data preprocessing to facilitate identification of risk factors for radiation therapy interruptions (RTI). METHODS: We analyzed demographic, behavioral, clinical, and neighborhood-level data for 2,130 patients treated with radiotherapy at the University of Tennessee Medical Center in Knoxville. Treatment interruptions were measured as missed days, adjusted for weekends and holidays. Multinomial logistic regression was used to identify factors associated with moderate (2-4 days) and severe (≥5 days) RTI. RESULTS: Moderate RTI occurred in 15.8% of patients, while 7.7% experienced severe RTI. Moderate delays were associated with genitourinary cancer (adjusted odds ratio (AOR), 3.81; 95% CI, 1.24 to 11.66), prostate cancer (AOR, 2.44; 95% CI, 1.34 to 4.46), and Medicaid coverage (AOR, 2.22; 95% CI, 1.32 to 3.73). Severe RTI was associated with marital status (AOR for divorced or separated patients, 1.86; 95% CI, 1.18 to 2.94), head and neck cancer (AOR, 2.31; 95% CI, 1.10 to 4.87), gynecologic cancer (AOR, 2.97; 95% CI, 1.30 to 6.79), Medicaid insurance (AOR, 3.43; 95% CI, 1.77 to 6.64), daily dose of ≤225 cGy (AOR, 2.55; 95% CI, 1.21 to 5.37), and a total dose of ≥6,000 cGy (AOR, 2.30; 95% CI, 1.09 to 4.88). Severe interruptions were also significantly associated with high neighborhood social vulnerability (AOR, 2.60; 95% CI, 1.32 to 5.09). CONCLUSION: Automated data preprocessing permitted efficient identification of treatment course length, marital status, disease site, Medicaid coverage, and socially vulnerable locations as significant factors associated with RTI. These findings underscore the need for data-driven risk assessment and intervention strategies to maintain cancer treatment quality at scale.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/cci-25-00218

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 17

  1. [1]Ohri N, Rapkin BD, Guha C, et al: Radiation therapy noncompliance and clinical outcomes in an urban academic cancer Center. Int J Radiat Oncol Biol Phys 95: 563- 570, 2016 27020104
  2. [2]Chow R, Hasan S, Choi J, et al: Effect of treatment interruptions on overall survival in patients with triple-negative breast cancer. J Natl Cancer Inst 115: 1029- 1035, 2023 37399094 PMC10483262
  3. [3]Rudat V, Nour A, Hammoud M, et al: Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy: Results of a single, institutional, retrospective study. Strahlenther Onkol 193: 375- 384, 2017 28233048 PMC5405099
  4. [5]Pozo G, Pérez-Escutia MA, Ruíz A, et al: Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites. Rep Pract Oncol Radiother 24: 239- 244, 2019 30858768 PMC6395853
  5. [6]Yao J-J, Jin Y-N, Wang S-Y, et al: The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: An observational, prospective analysis. BMC Cancer 18: 740- 747, 2018 30012115 PMC6048841
  6. [7]Gaudio E, Ammar N, Gunturkun F, et al: Defining radiation treatment interruption rates during the COVID-19 pandemic: Findings from an academic center in an underserved urban setting. Int J Radiat Oncol Biol Phys 116: 379- 393, 2023 36183931 PMC9584778
  7. [8]Lazarev S, Gupta V, Ghiassi-Nejad Z, et al: Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation. Adv Radiat Oncol 3: 62- 69, 2018 29556582 PMC5856974
  8. [9]Pepin AN, Zwart A, Danner M, et al: Treatment interruptions during stereotactic body radiotherapy for prostate cancer. Front Oncol 11: 796496, 2021 35127506 PMC8807506
  9. [10]Waddle MR, Chen RC, Arastu NH, et al: Unanticipated hospital admissions during or soon after radiation therapy: Incidence and predictive factors. Pract Radiat Oncol 5: e245- e253, 2015 25413398
  10. [11]Wakefield DV, Carnell M, Dove APH, et al: Location as destiny: Identifying geospatial disparities in radiation treatment interruption by neighborhood, race, and insurance. Int J Radiat Oncol Biol Phys 107: 815- 826, 2020 32234552 PMC13440333
  11. [12]Thomas K, Martin T, Gao A, et al: Interruptions of head and neck radiotherapy across insured and indigent patient populations. J Oncol Pract 13: e319- e328, 2017 28267393
  12. [13]Yarn C, Wakefield DV, Spencer S, et al: Insurance status and head and neck radiotherapy interruption disparities in the Mid-Southern United States. Head Neck 42: 2013- 2020, 2020 32141652
  13. [14]Hutten RJ, Weil CR, Gaffney DK, et al: Worsening racial disparities in utilization of intensity modulated radiation therapy. Adv Radiat Oncol 7: 100887, 2022 35360509 PMC8960883
  14. [16]Hashtarkhani S, Rashid R, Brett CL, et al: Cancer diagnosis categorization in electronic health records using large language models and BioBERT: Model performance evaluation study. JMIR Cancer 10.2196/72005 [epub ahead of print on October 2, 2025]. In press PMC12490771 41037674 · DOI
  15. [17]González Ferreira JA, Jaén Olasolo J, Azinovic I, et al: Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. Rep Pract Oncol Radiother 20: 328- 339, 2015 26549990 PMC4597087
  16. [19]Torres-Small S, Davies C, Kumsa FA, et al: Effects of rurality, socioeconomic status, and race on head and neck squamous cell carcinoma outcomes. Laryngoscope 135: 1715- 1723, 2025 39703100
  17. [20]Haggerty JL, Roberge D, Lévesque JF, et al: An exploration of rural-urban differences in healthcare-seeking trajectories: Implications for measures of accessibility. Health Place 28: 92- 98, 2014 24793139

Cited by

Sorted by citations

Authors
Kumsa, F. A., Brett, C. L., Hashtarkhani, S., Rashid, R., Chinthala, L., Zink, J. A., Davis, R. L., Shaban-Nejad, A., & Schwartz, D. L.
Affiliations
  • Center for Biomedical Informatics, Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN
  • University of Tennessee Graduate School of Medicine, Knoxville, TN
  • Department of Radiation Oncology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN
Venue
JCO Clinical Cancer Informatics
Published
2025-10
Issue
9
ISSN
2473-4276
Cited by
2
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review